The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Measurement of Adult Antibacterial Drug Use in 130 US Hospitals: Comparison of Defined Daily Dose and Days of Therapy
Abstract
BACKGROUND: Hospitals are advised to measure antibiotic use and monitor its relationship to resistance. The World Health Organization's recommended metric is the defined daily dose (DDD). An alternative measure is the number of days of therapy (DOT). The purpose of this study was to contrast these measures. METHODS: We measured the use of 50 antibacterial drugs that were administered to adults who were discharged from 130 US hospitals during 1 August 2002-31 July 2003. RESULTS: Of 1,795,504 patients, 1,074,174 received at least 1 dose of an antibacterial drug (59.8%). The mean (+/- standard deviation) of total antibacterial drug use measured by the number of DDDs per 1000 patient-days and the number of DOTs per 1000 patient-days were not significantly different (792+/-147 and 776+/-120, respectively; P=.137), although the correlation was poor (r=0.603). For some individual drugs, such as levofloxacin and linezolid, there was no significant difference between DDDs per 1000 patient-days and DOTs per 1000 patient-days, because the administered daily dosage was nearly equivalent to the DDD. When the administered dosage exceeded the DDD, such as for ampicillin-sulbactam and cefepime, estimates of use based on DDDs per 1000 patient-days significantly exceeded those based on DOTs per 1000 patient-days (P<.001). When the administered dosage was less than the DDD, such as for piperacillin-tazobactam and ceftriaxone, estimates of use based on DDDs per 1000 patient-days were significantly lower than those based on DOTs per 1000 patient-days (P<.001). CONCLUSION: The measurement of aggregate hospital antibiotic use by DDDs per 1000 patient-days and DOTs per 1000 patient-days is discordant for many frequently used antibacterial drugs, because the administered dose is dissimilar from the DDD recommended by the World Health Organization. DDD methods are useful for benchmarking purposes but cannot be used to make inferences about the number of DOTs or relative use for many antibacterial drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dellit, T. H., Owens, R. C., McGowan, J. E., Gerding, D. N., Weinstein, R. A., Burke, J. P., Huskins, W. C., Paterson, D. L., Fishman, N. O., Carpenter, C. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510393 · Cited by 3,362
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
System, A. R. F. T. N. (2004) · American Journal of Infection Control · doi:10.1016/j.ajic.2004.10.001 · Cited by 2,342
A review of uses of health care utilization databases for epidemiologic research on therapeutics
Schneeweiss, S., & Avorn, J. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.10.012 · Cited by 1,277
Shlaes, D. M., Gerding, D. N., John, Jr., Craig, W. A., Bornstein, D. L., Duncan, R. A., Eckman, M. R., Farrer, W. E., Greene, W. H., Lorian, V., et al. (1997) · Clinical Infectious Diseases · doi:10.1086/513766 · Cited by 780
Goldmann, D. A. (1996) · JAMA · doi:10.1001/jama.1996.03530270074035 · Cited by 753
Variation in antibiotic use in the European Union
Cars, O., Mölstad, S., & Melander, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04972-2 · Cited by 698
Fridkin, S. K., Steward, C. D., Edwards, J. R., Pryor, E. R., McGowan, Jr., Archibald, L. K., Gaynes, R. P., & Tenover, F. C. (1999) · Clinical Infectious Diseases · doi:10.1086/520193 · Cited by 486
Bantar, C., Sartori, B., Vesco, E., Heft, C., Saul, M., Salamone, F., & Oliva, M. E. (2003) · Clinical Infectious Diseases · doi:10.1086/375818 · Cited by 253
Harbarth, S., Harris, A. D., Carmeli, Y., & Samore, M. H. (2001) · Clinical Infectious Diseases · doi:10.1086/322677 · Cited by 169
Application of the ATC/DDD methodology to monitor antibiotic drug use
Natsch, S., Hekster, Y. A., Jong, R., Heerdink, E. R., Herings, R. M. C., & van der Meer, J. W. M. (1998) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01584358 · Cited by 122
Polk, R. E., Johnson, C. K., McClish, D. K., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/422647 · Cited by 117
Self-citationMüller, A., Monnet, D. L., Talon, D. R., Hénon, T., & Bertrand, X. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02605.x · Cited by 107
Fridkin, S. K., Lawton, R. M., Edwards, J. R., Tenover, F. C., McGowan, J. E., & Gaynes, R. P. (2002) · Emerging infectious diseases · doi:10.3201/eid0807.010465 · Cited by 95
Antibiotic prescribing policy and Clostridium difficile diarrhoea
O’Connor, K. A., Kingston, M., O’Donovan, M., Cryan, B., Twomey, C., & O’Mahony, D. (2004) · QJM · doi:10.1093/qjmed/hch076 · Cited by 75
Kern, W. V., Steib–Bauert, M., de With, K., Reuter, S., Bertz, H., Frank, U., & von Baum, H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh510 · Cited by 66
Alfandari, S., Leroy, O., de Botton, S., Yakoub‐Agha, I., Durand-Joly, I., Leroy-Cotteau, A., & Beaucaire, G. (2005) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2005.01.004 · Cited by 18
Cited by
Barlam, T. F., Cosgrove, S. E., Abbo, L. M., MacDougall, C., Schuetz, A. N., Septimus, E. J., Srinivasan, A., Dellit, T. H., Falck-Ytter, Y. T., Fishman, N. O., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw118 · Cited by 3,061
Self-citationInterventions to improve antibiotic prescribing practices for hospital inpatients
Davey, P., Brown, E., Charani, E., Fenelon, L., Gould, I. M., Holmes, A., Ramsay, C. R., Wiffen, P. J., & Wilcox, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003543.pub3 · Cited by 1,864
Cumulative Antibiotic Exposures Over Time and the Risk of Clostridium difficile Infection
Stevens, V., Dumyati, G., Fine, L. S., Fisher, S. G., & van Wijngaarden, E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir301 · Cited by 446
Evaluation of Hospital Room Assignment and Acquisition of Clostridium difficile Infection
Shaughnessy, M. K., Micielli, R. L., DePestel, D. D., Arndt, J., Strachan, C. L., Welch, K. B., & Chenoweth, C. E. (2011) · Infection Control & Hospital Epidemiology · doi:10.1086/658669 · Cited by 311
Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From 2006 to 2012
Baggs, J., Fridkin, S. K., Pollack, L. A., Srinivasan, A., & Jernigan, J. A. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.5651 · Cited by 268
Metadata
- Authors
- Polk, R. E., Fox, C., Mahoney, A., Letcavage, J., & MacDougall, C.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-03-01
- Volume
- 44
- Issue
- 5
- Pages
- 664-670
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2122173144
- Cited by
- 414
- References
- 17
- FWCI
- 15.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.